Article summary
The European Medicines Agency (EMA) has issued a joint statement with the International Coalition of Medicines Regulatory Authorities (ICMRA) urging countries to commit to strengthening the global collaboration to fight coronavirus (COVID-19). The statement calls for governments and research communities to prioritise large-scale, well designed clinical trials as those are key to gathering the robust evidence required by regulators to make decisions on the safety and efficacy of proposed coronavirus treatments. EMA and ICMRA called on the pharmaceutical industry to step up their co-operation on drug development and address issues such as shortages of drugs as well as supply and manufacturing problems, and reaffirmed their global commitment to ensuring equitable access to coronavirus treatment.
To continue reading this news article, as well as thousands of others like it, sign in with LexisNexis or register for a free trial